These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19578390)

  • 1. Anticitrullinated protein/peptide antibodies in rheumatoid arthritis.
    Gross WL; Moosig F; Lamprecht P
    Dtsch Arztebl Int; 2009 Mar; 106(10):157-8. PubMed ID: 19578390
    [No Abstract]   [Full Text] [Related]  

  • 2. The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens.
    Egerer K; Feist E; Burmester GR
    Dtsch Arztebl Int; 2009 Mar; 106(10):159-63. PubMed ID: 19578391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis].
    Lequerré T; Richez C
    Rev Prat; 2012 Oct; 62(8):1088-9. PubMed ID: 23227605
    [No Abstract]   [Full Text] [Related]  

  • 4. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
    Zendman AJ; van Venrooij WJ; Pruijn GJ
    Rheumatology (Oxford); 2006 Jan; 45(1):20-5. PubMed ID: 16188946
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?
    Zhao J; Liu X; Wang Z; Liu R; Li Z
    J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.
    Aggarwal R; Liao K; Nair R; Ringold S; Costenbader KH
    Arthritis Rheum; 2009 Nov; 61(11):1472-83. PubMed ID: 19877103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.
    van Steenbergen HW; Ajeganova S; Forslind K; Svensson B; van der Helm-van Mil AH
    Ann Rheum Dis; 2015 Jan; 74(1):e3. PubMed ID: 25288634
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.
    Li X; Wang Z; Yi H; Xie J; Zhu N
    Clin Rheumatol; 2020 Apr; 39(4):1111-1120. PubMed ID: 31858337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.
    van Venrooij WJ; Zendman AJ
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):36-9. PubMed ID: 18270856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    Jansen TL
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
    [No Abstract]   [Full Text] [Related]  

  • 13. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
    Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
    Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
    Tant L; Steinfeld S
    Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical interest of autoantibodies directed against citrullinated peptides in Indian patients with rheumatoid arthritis.
    Goëb V
    Indian J Med Sci; 2009 Mar; 63(3):89-91. PubMed ID: 19359775
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 17. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
    Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
    Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to citrullinated proteins: pathogenic and diagnostic significance.
    Holers VM
    Curr Rheumatol Rep; 2007 Oct; 9(5):396-400. PubMed ID: 17915095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins.
    Bizzaro N; Tampoia M
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):16-20. PubMed ID: 18270852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Mofidi M; Moghadam A
    Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.